Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03436082 · ClinicalTrials.gov registry record
Post-Market Surveillance With a Novel mHealth Platform
A clinical trial of Atrial Fibrillation and Gastrectomy, sponsored by Yale University.
- Completed
- Registry status
- 60
- Enrollment target
- 2
- Study locations
NCT03436082 is a study of Atrial Fibrillation and Gastrectomy that has completed, run by Yale University. The registered enrollment target is 60 participants, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT03436082, a study of Atrial Fibrillation and Gastrectomy, has completed, sponsored by Yale University.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
- 2
- Study locations
Study Summary
This is a study to pilot the feasibility of using a novel patient-led, smartphone-based mobile health platform (Hugo) for real-world surveillance of outcomes of patients after they undergo a bariatric surgical procedure (either sleeve gastrectomy or gastric bypass) and catheter-based atrial fibrillation ablation
Conditions Studied
Interventions
- DEVICE A mobile health platform
Study Locations (2)
Connecticut
- Yale New Haven Hospital - New Haven
Minnesota
- Mayo Clinic - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2018-01-26 |
| Est. Completion | 2018-12-25 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03436082
The ClinicalTrials.gov registry entry for NCT03436082 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,997-participant average among 202 other Atrial Fibrillation trials with a reported enrollment target (98% lower). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Atrial Fibrillation appearing as the primary indexed condition, and to 1 intervention - of which A mobile health platform is the first listed.
NCT03436082 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Connecticut, Minnesota.
Frequently Asked Questions
What is clinical trial NCT03436082 about?
NCT03436082 is a clinical study titled "Post-Market Surveillance With a Novel mHealth Platform". This is a study to pilot the feasibility of using a novel patient-led, smartphone-based mobile health platform (Hugo) for real-world surveillance of outcomes of patients after they undergo a bariatric surgical procedure (either sleeve gastrectomy or gastric bypass) and catheter-based atrial fibrilla...
What is the current status of trial NCT03436082?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2018-01-26. Estimated completion is 2018-12-25.
What conditions does trial NCT03436082 study?
This clinical trial studies the following conditions: Atrial Fibrillation, Gastrectomy.
What interventions are being tested in trial NCT03436082?
The interventions under investigation include: A mobile health platform (DEVICE).
Who is sponsoring clinical trial NCT03436082?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03436082 being conducted?
This trial has 2 study locations across Connecticut, Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Atrial Fibrillation
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
TIRzepatide for the Treatment of Obesity in Patients With Atrial Fibrillation
RECRUITING · Phase 2
-
Amiodarone for the Prevention of Atrial Fibrillation After Minimally Invasive Esophagectomy in Patients With Esophageal Cancer
RECRUITING · Phase 2
-
The Dynamics of Human Atrial Fibrillation
RECRUITING
-
Renal Denervation + PVI vs PVI Alone for Persistent AF
RECRUITING · NA
-
Pericardiotomy in Cardiac Surgery
RECRUITING · NA
-
CellFX® Nanosecond Pulsed Field Ablation (nsPFA)™ Cardiac Surgery Clamp System to Treat Atrial Fibrillation
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.